Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02367 GIANT BIOGENE
RT Nominal down50.100 -1.100 (-2.148%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--024,17026,0870
Property, plant, equip. & others663,46935.010%491,421274,336240,363258,722
Land & other Lease Assets48,155-20.052%60,23359,19040,35141,218
Intangible Assets7,3578.976%6,7517,5988,7829,154
Interests in Asso. & JCEs0--0000
Other Non-current Assets119,018182.804%42,08571,59251,42729,588

837,99939.553%600,490436,886367,010338,682
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories200,4408.997%183,89589,39464,65650,863
Trade Receivables102,02946.973%69,42065,63954,52317,260
Cash & Bank Balances2,503,99988.136%1,330,9517,103,000367,80572,323
Other Current Assets1,328,61139.345%953,469183,2891,797,1141,317,809
Assets Held for Sale0--0000

4,135,07962.944%2,537,7357,441,3222,284,0981,458,255
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables133,109143.553%54,65323,61231,94622,779
S-T Debt & Leases1,56377.412%881000
Other Current Liabilities395,94075.684%225,3716,819,4302,141,944603,275
Liab asso w/ Assets Held for Sale0--0000

530,61288.894%280,9056,843,0422,173,890626,054
Net Current Assets3,604,46759.714%2,256,830598,280110,208832,201
Total Assets Less Current Liabilities4,442,46655.477%2,857,3201,035,166477,2181,170,883
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases1,166-31.613%1,705000
Other Non-current Liabilities70,250278.054%18,58218,35519,21519,434

71,416252.028%20,28718,35519,21519,434
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital630.000%638100
  Reserves4,362,07753.952%2,833,4091,016,730458,0031,147,698
  Others0--0000
Shareholders' Funds4,362,14053.950%2,833,4721,016,811458,0031,147,698
Non-controlling Interests8,910150.211%3,561003,751
Others0--0000

4,371,05054.071%2,837,0331,016,811458,0031,151,449
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments506,22343.992%351,56352,96071,45574,534
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 14/11/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 983,164
%Change47.414%
EPS / (LPS)RMB 0.990
NBV Per Share (¥)RMB 5.806
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.